What is the current market valuation of the helicobacter pylori-test market in the UK?

The market valuation was $121.29 Million in 2024. Read More

What is the projected market size for the helicobacter pylori-test market by 2035?

The projected valuation for 2035 is $252.12 Million. Read More

What is the expected CAGR for the helicobacter pylori-test market during the forecast period 2025 - 2035?

The expected CAGR is 6.88% during the forecast period 2025 - 2035. Read More

Which companies are the key players in the UK helicobacter pylori-test market?

Key players include Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Siemens Healthineers, and Becton, Dickinson and Company. Read More

What are the main segments of the helicobacter pylori-test market based on test type?

The main segments are Non-endoscopic, valued between $70.0 Million and $150.0 Million, and Endoscopic, valued between $51.29 Million and $102.12 Million. Read More

How does the technology segment break down in the helicobacter pylori-test market?

The technology segment includes Immunoassays, valued between $40.0 Million and $80.0 Million, Point of Care, valued between $30.0 Million and $60.0 Million, and Molecular Diagnostics, valued between $51.29 Million and $112.12 Million. Read More

What are the end-user segments in the helicobacter pylori-test market?

End-user segments include Hospitals & Clinics, valued between $40.0 Million and $85.0 Million, Diagnostic Laboratories, valued between $50.0 Million and $110.0 Million, and Others, valued between $31.29 Million and $57.12 Million. Read More

What factors are driving growth in the helicobacter pylori-test market?

Growth appears driven by advancements in diagnostic technologies and increasing awareness of helicobacter pylori infections. Read More

How does the UK helicobacter pylori-test market compare to other regions?

While specific regional comparisons are not provided, the UK market shows promising growth potential with a projected valuation increase. Read More

What trends are expected to shape the helicobacter pylori-test market in the coming years?

Trends may include increased adoption of molecular diagnostics and point-of-care testing, reflecting a shift towards more efficient healthcare solutions. Read More

UK Helicobacter Pylori Test Market

ID: MRFR/HC/49449-HCR

200 Pages

Nidhi Mandole

Last Updated: February 06, 2026

UK Helicobacter Pylori Test Market Research Report By Type (Non-endoscopic, Endoscopic), By Technology (Immunoassays, Point of care, Molecular Diagnostics) and By End User (Hospitals & clinics, Diagnostic laboratories, Others) - Growth & Industry Forecast 2025 To 2035

UK Helicobacter Pylori Test Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Test Type (USD Million)
  1. 4.1.1 Non-endoscopic
  2. 4.1.2 Endoscopic
2. 4.2 Life Sciences, BY Technology (USD Million)
  1. 4.2.1 Immunoassays
  2. 4.2.2 Point of care
  3. 4.2.3 Molecular Diagnostics
3. 4.3 Life Sciences, BY End User (USD Million)
  1. 4.3.1 Hospitals & clinics
  2. 4.3.2 Diagnostic laboratories
  3. 4.3.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Thermo Fisher Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 F. Hoffmann-La Roche Ltd (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Siemens Healthineers (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Becton, Dickinson and Company (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Halyard Health (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Bio-Rad Laboratories (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Meridian Bioscience, Inc. (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY TEST TYPE
3. 6.3 UK MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 UK MARKET ANALYSIS BY END USER
5. 6.5 KEY BUYING CRITERIA OF LIFE SCIENCES
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF LIFE SCIENCES
8. 6.8 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
9. 6.9 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 SUPPLY / VALUE CHAIN: LIFE SCIENCES
11. 6.11 LIFE SCIENCES, BY TEST TYPE, 2024 (% SHARE)
12. 6.12 LIFE SCIENCES, BY TEST TYPE, 2024 TO 2035 (USD Million)
13. 6.13 LIFE SCIENCES, BY TECHNOLOGY, 2024 (% SHARE)
14. 6.14 LIFE SCIENCES, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
15. 6.15 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
16. 6.16 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TEST TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Life Sciences Market Segmentation

Life Sciences By Test Type (USD Million, 2025-2035)

Non-endoscopic
Endoscopic

Life Sciences By Technology (USD Million, 2025-2035)

Immunoassays
Point of care
Molecular Diagnostics

Life Sciences By End User (USD Million, 2025-2035)

Hospitals & clinics
Diagnostic laboratories
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”